56 DAFTAR PUSTAKA Bologna-Molina, R., Mosqueda-Taylor, A., Molina-Frechero, N., Mori-Estevez, A.D., Sánchez-Acuña G., 2013. Comparison of The Value of PCNA and Ki-67 as Markers of Cell Proliferation in Ameloblastic tumors. Medicina Oral, Patologia Oral y Cirugia Bucal, 18(2). Pp: e174- e179. Chen, V.W., Ruiz, B., Killeen, J.L., Coté, T.R., Wu, X.C., Correa, C.N., 2003. Pathology and Classification of Ovarian Tumors. Cancer, 97(10 Suppl), pp.2631–2642. Davis, M. et al., 2014. Comparison of Clinical Outcomes of Patients with Clear Cell and Endometrioid Ovarian Cancer Associated with Endometriosis to Papillary Serous Carcinoma of The Ovary. Gynecologic Oncology, 132(3), pp.760–766. De Azambuja, E. et al., 2007. Ki-67 as Prognostic Marker in Early Breast Cancer: A Meta-analysis of Published Studies Involving 12,155 Patients. British Journal of Cancer, 96(10), pp.1504–1513. Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B., Galloway, D., 1997. Inhibition of CDK Activity and PCNA-dependent DNA Replication p21 is Blocked by Interaction with The HPV-16 E7 Oncoprotein. Genes and Development, 11(16), pp.2090–2100. Gadducci, A. et al., 2009. Serum and Tissue Biomarkers as Predictive and Prognostic Variables in Epithelial Ovarian Cancer. Critical Reviews in Oncology/Hematology, 69(1), pp.12–27. Georgescu, C. V., Florescu, M., Simionescu, C., 1999. Value of Immunohistochemistry in Confirming Undifferentiated Ovarian Carcinomas. Romanian Journal of Morphology and Embryology = Revue Roumaine de Morphologie et Embryologie, 45, pp.133–142. PERBEDAAN EKSPRESI KI-67 DAN PCNA PADA KANKER OVARIUM EPITELIAL TIPE SEROSUM, MUSINOSUM, ENDOMETRIOID, DAN SEL JERNIH AMANDA SARI PUSPITA Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/
5
Embed
MUSINOSUM, ENDOMETRIOID, DAN SEL JERNIH AMANDA …etd.repository.ugm.ac.id/downloadfile/94757/potongan/S1-2015-329147...57 Giurgea, L.N., Ungureanu, C., Mihailovici, M.S., 2012. The
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
56
DAFTAR PUSTAKA
Bologna-Molina, R., Mosqueda-Taylor, A., Molina-Frechero,
N., Mori-Estevez, A.D., Sánchez-Acuña G., 2013.
Comparison of The Value of PCNA and Ki-67 as Markers
of Cell Proliferation in Ameloblastic tumors. Medicina
Oral, Patologia Oral y Cirugia Bucal, 18(2). Pp: e174-
X.C., Correa, C.N., 2003. Pathology and Classification
of Ovarian Tumors. Cancer, 97(10 Suppl), pp.2631–2642.
Davis, M. et al., 2014. Comparison of Clinical Outcomes
of Patients with Clear Cell and Endometrioid Ovarian
Cancer Associated with Endometriosis to Papillary
Serous Carcinoma of The Ovary. Gynecologic Oncology,
132(3), pp.760–766.
De Azambuja, E. et al., 2007. Ki-67 as Prognostic Marker
in Early Breast Cancer: A Meta-analysis of Published
Studies Involving 12,155 Patients. British Journal of
Cancer, 96(10), pp.1504–1513.
Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman,
B., Galloway, D., 1997. Inhibition of CDK Activity and
PCNA-dependent DNA Replication p21 is Blocked by
Interaction with The HPV-16 E7 Oncoprotein. Genes and
Development, 11(16), pp.2090–2100.
Gadducci, A. et al., 2009. Serum and Tissue Biomarkers as
Predictive and Prognostic Variables in Epithelial
Ovarian Cancer. Critical Reviews in
Oncology/Hematology, 69(1), pp.12–27.
Georgescu, C. V., Florescu, M., Simionescu, C., 1999.
Value of Immunohistochemistry in Confirming
Undifferentiated Ovarian Carcinomas. Romanian Journal
of Morphology and Embryology = Revue Roumaine de
Morphologie et Embryologie, 45, pp.133–142.
PERBEDAAN EKSPRESI KI-67 DAN PCNA PADA KANKER OVARIUM EPITELIAL TIPE SEROSUM,MUSINOSUM,ENDOMETRIOID, DAN SEL JERNIHAMANDA SARI PUSPITAUniversitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/
Transcription by 12 S E1A Oncoprotein Requires CBP.
The Jurnal of Biological Chemistry, 273(28), pp.17303–
17306.
Klintman, M., Bendahl, P.O., Grabau, D., Lövgren, K.,
Malmström, P., Fernö, M., 2010. The Prognostic Value
of Ki67 is Dependent on Estrogen Receptor Status and
Histological Grade in Premenopausal Patients with
PERBEDAAN EKSPRESI KI-67 DAN PCNA PADA KANKER OVARIUM EPITELIAL TIPE SEROSUM,MUSINOSUM,ENDOMETRIOID, DAN SEL JERNIHAMANDA SARI PUSPITAUniversitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/
58
Node-negative Breast Cancer. Modern pathology: An
Official Journal of The United States and Canadian
Academy of Pathology, Inc, 23(2), pp.251–259.
Köbel, M. et al., 2008. Ovarian Carcinoma Subtypes are
Different Diseases: Implications for Biomarker
Studies. PLoS Medicine, 5(12), pp.1749–1760.
Komiyama, S.I., Aoki, D., Katsuki, Y., Nozawa, S., 2006.
Proliferative Activity of Early Ovarian Clear Cell
Adenocarcinoma Depends On Association with
Endometriosis. European Journal of Obstetrics
Gynecology and Reproductive Biology, 127(1), pp.130–
1994. p53, c-myc p62 and Proliferating Cell Nuclear
Antigen (PCNA) Expression in Non-Hodgkin's Lymphomas.
Journal of Clinical Pathology, 47, pp.9–14.
Kumar, V., Abbas, A. K., Aster J. C., 2013. Female
Genital System and Breast. Robbins and Cotran
Pathologic Basic of Disease. 9 edn. Elsevier Saunder,
Philadelphia, pp.695-698.
Kurman, R. & Shih, I., 2010. The Origin and Pathogenesis
of Epithelial Ovarian Cancer- A Proposed Unifying
Theory. The American Journal of Surgical Pathology,
34(3), pp.433–443.
Levanon, K., Crum, C., Drapkin, R., 2008. New Insights
Into The Pathogenesis of Serous Ovarian Cancer and Its
Clinical Impact. Journal of Clinical Oncology, 26(32),
pp.5284–5293.
Le Page, C., Huntsman, D.G., Provencher, D.M., Mes-
Masson, A.M., 2010. Predictive and Prognostic Protein
Biomarkers in Epithelial Ovarian Cancer:
Recommendation for Future Studies. Cancers, 2(2),
pp.913–954.
Luporsi, E. et al., 2012. Ki-67: Level of Evidence and
Methodological Considerations for Its Role in The
PERBEDAAN EKSPRESI KI-67 DAN PCNA PADA KANKER OVARIUM EPITELIAL TIPE SEROSUM,MUSINOSUM,ENDOMETRIOID, DAN SEL JERNIHAMANDA SARI PUSPITAUniversitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/
59
Clinical Management of Breast Cancer: Analytical and
Critical Review. Breast Cancer Research and Treatment,
132(3), pp.895–915.
Oemiati, R., Rahajeng, E. & Kristanto, A.Y., 2011.
Prevalensi Tumor dan Beberapa Faktor yang
Mempengaruhinya di Indonesia. Buletin Penelitian
Kesehatan, 39(4), pp.190-204.
Paunesku, T. et al., 2001. Proliferating Cell Nuclear
Antigen (PCNA): Ringmaster of The Genome.
International journal of radiation biology, 77(10),
pp.1007–1021.
Pectasides, D., Pectasides, E., Psyrri, A.,
Economopoulos, T., 2006. Treatment Issues in Clear
Cell Carcinoma of The Ovary: A Different Entity?
Oncologist, 11(10), pp.1089–94.
Reitmaier, M., Rudlowski, C., Biesterfeld S., Rath, W.,
Schröder, W., 2000.[Comparative Studies on The
Biological Significance of The Marker for
Proliferation Ki-67-Antigen and PCNA in Primary
Ovarian Carcinoma]. Zentralbl Gynakol, 122(7),
pp.361-367.
Rubin, E. et al., 2014. The Female Reproductive System.
Essentials of Rubin’s Pathology. 6 edn. Lippincott
Williams & Wilkins, Philadelphia, pp.518-523.
Sajeevan, T. et al., 2014. Immunohistochemical Study of
p53 and Proliferating Cell Nuclear Antigen Expression
in Odontogenic Keratocyst and Periapical Cyst. Journal
of Pharmacy and Bioallied Sciences, 6(5), p.52.
Siegel, R., Naishadham, D. & Jemal, A., 2012. Cancer
Statistics , 2012. CA: A Cancer Journal for
Clinicians, 62(1), pp.10–29.
Tan, D.S.P. & Kaye, S., 2007. Ovarian Clear Cell
Adenocarcinoma: A Continuing Enigma. Journal of
clinical pathology, 60(4), pp.355–360.
PERBEDAAN EKSPRESI KI-67 DAN PCNA PADA KANKER OVARIUM EPITELIAL TIPE SEROSUM,MUSINOSUM,ENDOMETRIOID, DAN SEL JERNIHAMANDA SARI PUSPITAUniversitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/
60
Thomas, H. et al., 1995. Proliferating Cell Nuclear
Antigen (PCNA) Immunostaining-A Prognostic Factor in
Ovarian Cancer? British journal of cancer, 71(2),
pp.357–362.
Tortora, G. J., & Derrickson, B.H., 2011. The
Reproductive Systems. Principle Anatomy and
Physiology. 13 edn. John Wiley&Sons, Asia, pp.1143-
1150.
Widagdo, R., 2009. Angka Harapan Hidup Penerita Kanker
Ovarium Rumah Sakit Sardjito. Bagian Obstetri dan
Ginekologi FK UGM, Yogyakarta.
Yerushalmi, R., Woods, R., Ravdin, P.M., Hayes, M.M.,
Gelmon, K., 2010. Ki67 in Breast Cancer: Prognostic
and Predictive Potential. The Lancet Oncology, 11(2),
pp.174–183.
Zhong, W. et al., 2008. Ki-67 and PCNA Expression in
Prostate Cancer and Benign Prostatic Hyperplasia.
Clinical and investigative medicine. Medecine clinique
et experimentale, 31(1), pp.E8–E15.
PERBEDAAN EKSPRESI KI-67 DAN PCNA PADA KANKER OVARIUM EPITELIAL TIPE SEROSUM,MUSINOSUM,ENDOMETRIOID, DAN SEL JERNIHAMANDA SARI PUSPITAUniversitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/